Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.08.01
自力董事候选人声明
2020.08.01
第四届董事会第三十六次聚会决议通告
2020.07.31
关于稳定价钱行动、稳定价钱时代竣事及逾额配售权失效的通告
2020.07.31
关于公司问询函中有关财务事项的说明
2020.07.31
关于公司问询函中有关财务事项的说明
2020.07.31
关于对深圳证券生意所2019年年报问询函回复的通告
2020.07.15
2020年半年度业绩预告
2020.07.08
关于境外上市外资股(H股)挂牌并上市生意的通告
2020.07.07
关于境外上市外资股(H股)配发效果的通告
2020.07.03
关于境外上市外资股(H股)果真刊行价钱的通告
第一页
上一页
28
29
30
31
32
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】